Unlock stock picks and a broker-level newsfeed that powers Wall Street.
60.29
+1.75
+(2.99%)
At close: 4:00:00 PM EDT
59.97
-0.32
(-0.53%)
After hours: 5:10:23 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.03 | -0.02 | -0.04 | 0.21 |
| Low Estimate | -0.05 | -0.03 | -0.08 | 0.15 |
| High Estimate | -0.02 | -0.01 | 0.01 | 0.29 |
| Year Ago EPS | -0.04 | -0.1 | -2.08 | -0.04 |
Revenue Estimate
| Currency in GBP | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 8 | 8 |
| Avg. Estimate | 41.47M | 53.02M | 243.22M | 456.08M |
| Low Estimate | 33.5M | 43.54M | 204.75M | 364.26M |
| High Estimate | 53.2M | 70.51M | 316.01M | 618.83M |
| Year Ago Sales | -- | -- | 33.49M | 243.22M |
| Sales Growth (year/est) | 0.00% | 0.00% | 626.15% | 87.52% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.13 | -0.21 | -0.41 | -0.15 |
| EPS Actual | -0.04 | -0.1 | -0.56 | -0.4 |
| Difference | 0.09 | 0.11 | -0.15 | -0.25 |
| Surprise % | 69.57% | 50.67% | -36.59% | -166.67% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.03 | -0.02 | -0.04 | 0.21 |
| 7 Days Ago | -0.03 | -0.02 | -0.04 | 0.21 |
| 30 Days Ago | -0.05 | -0.01 | -0.06 | 0.29 |
| 60 Days Ago | -0.07 | -0.02 | -0.37 | 0.6 |
| 90 Days Ago | -0.11 | -0.11 | -0.76 | -0.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | 3 | 3 | 3 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VRNA | 18.75% | 80.69% | 98.20% | 666.67% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Overweight to Overweight | 2/28/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/28/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/21/2025 |
| Initiated | Roth MKM: Buy | 1/10/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 1/8/2025 |
Related Tickers
EWTX Edgewise Therapeutics, Inc.
15.52
-22.90%
SRRK Scholar Rock Holding Corporation
32.54
+8.25%
MDGL Madrigal Pharmaceuticals, Inc.
334.60
+3.28%
BBIO BridgeBio Pharma, Inc.
34.62
+4.85%
CYTK Cytokinetics, Incorporated
40.25
+7.33%
INSM Insmed Incorporated
73.44
+2.00%
AXSM Axsome Therapeutics, Inc.
109.75
-1.72%
SWTX SpringWorks Therapeutics, Inc.
46.52
+11.08%
WVE Wave Life Sciences Ltd.
7.57
-2.20%
RNA Avidity Biosciences, Inc.
29.77
+11.33%